Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A trial investigating ORC-13661 in healthy volunteers

Trial Profile

A trial investigating ORC-13661 in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 27 Sep 2018

At a glance

  • Drugs ORC-13661 (Primary)
  • Indications Hearing loss
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Most Recent Events

    • 27 Sep 2018 Status changed from planning to recruiting, as reported in a Decibel Therapeutics media release.
    • 07 Feb 2018 New trial record
    • 05 Feb 2018 According to an Oricula Therapeutics media release, the US FDA has granted permission to begin volunteer human testing of ORC-13661.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top